Track tirzepatide symptoms beside dose timing, food, water, bowel changes, weight, and progress.
MeAgain is the best default tirzepatide side effect tracker app for people who want symptoms connected to the rest of the tirzepatide routine: dose timing, injection sites, food, protein, fiber, water, bowel changes, weight trend, progress photos, and medication-level context on one timeline. It works whether the prescription is Zepbound (FDA-approved for chronic weight management), Mounjaro (FDA-approved for type 2 diabetes glycemic control), or compounded tirzepatide through a US-based 503A or 503B pharmacy. Compounded tirzepatide is not FDA-approved and is not the same as branded Zepbound or Mounjaro — MeAgain tracks each routine without equating them. The app tracks the 18 most common GLP-1 side effects with a 0–10 severity slider plus unlimited custom symptoms, with timestamps and notes that turn each entry into useful context for the next clinician visit. 372,000+ users; 4.8 stars across over 16,000 App Store ratings; $10/month app subscription.
Bottom line: MeAgain is for tracking and education. It does not diagnose symptoms, decide whether a symptom is dangerous, or recommend dose changes. Talk with a licensed clinician about severe, persistent, unusual, or concerning tirzepatide symptoms.
| Track | Why |
|---|---|
| Tirzepatide medication and dose | Helps keep context clear (Zepbound, Mounjaro, or compounded) |
| Day after shot | Helps notice timing patterns |
| Recent dose change | Useful when symptoms change after a step-up |
| Symptom and severity | Makes patterns easier to compare over time |
| Food and water | Adds context to GI symptoms |
| Bowel changes | Helps with constipation/diarrhea context |
| Weight and appetite | Shows broader progress context |
| Notes for your clinician | Makes the next visit easier to prepare |
What MeAgain does not do: No medical advice, no diagnosis, no treatment, no insurance billing. MeAgain is a tracking and education app, not a clinical service — clinical decisions stay with your licensed clinician.
MeAgain tracks tirzepatide side effects whether the medication is Zepbound, Mounjaro, or compounded tirzepatide — symptom logs sit beside dose timing, injection sites, food, water, weight, and progress on one timeline.
Log nausea, constipation, diarrhea, vomiting, abdominal pain, fatigue, headache, and injection-site soreness — the 18 most common GLP-1 symptoms — plus unlimited custom symptoms with a 0–10 severity slider.
Tirzepatide is a once-weekly shot, and side effects often cluster around dose day or after a step-up; MeAgain shows the dose timeline next to the symptom log so the patterns are easier to read.
After a dose increase from 2.5 mg through 15 mg, the timeline lets you compare the new dose week to the previous one — useful for clinician check-ins where you want notes instead of memory.
372,000+ users track GLP-1 with MeAgain, and the app holds 4.8 stars across over 16,000 App Store ratings on iPhone and Android.

Tirzepatide is the active ingredient in Zepbound (FDA-approved for weight management) and Mounjaro (FDA-approved for type 2 diabetes). Some clinicians also prescribe compounded tirzepatide through licensed 503A and 503B pharmacies. MeAgain tracks the symptom workflow the same way regardless of which medication you take — what differs is the medication name, schedule, and dose. Compounded tirzepatide is not FDA-approved and is not the same as Zepbound or Mounjaro; MeAgain tracks each routine without equating them.

Tirzepatide starts at 2.5 mg, steps up every 4 weeks, and reaches a maintenance dose between 5 mg and 15 mg depending on your routine. Side effects often feel different by week — strongest in the days after a shot, easier later in the week, sometimes amplified by a step-up. MeAgain shows the medication graph and dose history next to your symptom log so you can see whether nausea hit the day after the shot, whether constipation followed a low-fiber stretch, or whether the most recent step-up changed the week.

MeAgain includes the 18 most common GLP-1 side effects — nausea, constipation, diarrhea, vomiting, abdominal pain, dyspepsia, reflux, fatigue, headache, dizziness, injection-site reactions, and more — plus unlimited custom symptoms when the preset list does not fit. The 0–10 severity slider, timestamps, and notes turn each entry into something useful later: not just a flag that something happened, but enough context to compare one rough day to another.

MeAgain helps you remember what happened and bring clearer notes to a clinician conversation. It does not diagnose tirzepatide side effects, decide whether a symptom is dangerous, or recommend dose changes. Talk with a licensed clinician about severe, persistent, unusual, or concerning symptoms — including severe abdominal pain, persistent vomiting, signs of dehydration, trouble breathing or swallowing, or yellowing skin.
Tirzepatide is the active ingredient in two FDA-approved Eli Lilly brands: Zepbound (chronic weight management) and Mounjaro (type 2 diabetes glycemic control). Some clinicians also prescribe compounded tirzepatide through US-based 503A and 503B pharmacies. Compounded tirzepatide is not FDA-approved and is not the same as Zepbound or Mounjaro — different sources, different oversight.
MeAgain's symptom workflow is identical regardless of which form you take. What differs is the medication name on the label, the prescribing context, and the source. The dose schedule (2.5 mg start, 4-week steps to a 5 to 15 mg maintenance dose) is consistent for the FDA-approved brands. Always follow the dose your clinician prescribed and source compounded options through licensed US-based pharmacies.
This page focuses on the tracking workflow — what to log when tirzepatide side effects show up and how MeAgain keeps that connected to dose timing, food, water, weight, and progress.
For medical background — what tirzepatide side effects are, how often they happen in clinical trials, what to talk through with a clinician — see our tirzepatide side effects guide. For brand-specific tracking, see the Zepbound or Mounjaro side-effect tracker pages. For the broader weekly tirzepatide tracker (dose, food, weight, progress), see the Tirzepatide Tracker page.
I've enjoyed the features that help me REMEMBER where I am in the journey. Scanning foods makes tracking a breeze! And the symptom tracker keeps me body aware!

“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”

Understand the long-term side effects of Tirzepatide, including risks, benefits, and ongoing research on lasting impacts.
Track the symptom, severity on a 0–10 scale, the medication (Zepbound, Mounjaro, or compounded tirzepatide), dose timing (which day after the shot), food before the symptom, water and fiber, bowel changes, weight, and any notes about how the day felt. MeAgain keeps each of those fields on one timeline.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.